With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Kim Kardashian and Kanye West would be fighting once again Sep 19, 2020
- Chiara Ferragni supports the LGBTQ + community Jun 30, 2021
- “Crazy was little”: Laura León admitted what happened to her fame when she became “La Tesorito” Sep 21, 2020
- 3 years after the constitutional pact: signatories of the agreement agree to continue with the process Nov 14, 2022
- The Community denies the statements of the central government spokesperson on the illegal irrigation files Aug 24, 2021
- Kylie Jenner is going to change her son’s name, but she doesn’t know when yet Nov 26, 2022
- They set a hearing for the Valentina González case: lawyer asks to formalize 2 people and decree roots Nov 10, 2022